The abundance of GPC1 also positively correlates with disease severity of pancreatic cancer patients, independently on surgical treatment, suggesting that GPC1 is a surgery-independent diagnostic biomarker [263,266]. The gene discussed is GPC1; the disease is pancreatic neoplasm.